From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona’s bioscience industry is growing rapidly and reached nearly 30,000 jobs spanning 2,160 business establishments in 2018. Industry employment has grown by 15 percent since 2016—twice the growth rate of the nation—with each of the five major subsectors adding jobs during the period. Arizona’s universities conducted nearly $580 million in R&D activities in bioscience-related fields in 2018, fueled in part by steadily increasing NIH awards to Arizona institutions since 2016. Venture capital investments in Arizona bioscience companies increased in 2019, and during the 2016-19 period totaled $349 million. Arizona inventors have been awarded 2,178 bioscience-related patents since 2016, among the second quintile of states in patent activity.
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
With a global reach of 19 countries, partner network expands across U.S., Canada, Panama and Australia.
A widely respected and tireless civic leader, Rick Myers is a visionary and a strong advocate for promoting the biosciences in Arizona. Rick serves as the Governor-appointed Chair for the Arizona Board of Regents and advocates for growing the research enterprise and promoting biosciences.
Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
Revolutionary technique may enable new findings in what drives tumor cell growth and new targeted treatment options for patients1
SynCardia Publishes 1st Brochure for Total Artificial Heart Patients & Their Caregivers 12-Page Resource Describes How the Total Artificial Heart Works, What to Expect Before & After Surgery and the Steps to Patient Discharge Using the Freedom® Driver
- AZBioPEERS: What is my company worth? Establishing a valuation
- Preparing Your NIH SBIR/STTR CRP and Phase IIB Application
- AZBioPEERS: Perfecting your “virtual” pitch
- Arizona Bioscience Week - AZBW 2020
- 09/13/2020 - 09/19/2020
- AZBioPEERS: Investment activity in the age of COVID-19